Ethan Shen Ph.D.
CIK: 0002099921
Transaction Breakdown
Open Market Buys (P)3 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Shen Ethan PhD
Shen Ethan PhD (SEC CIK 0002099921) files insider reports with the SEC as SL Science Holding Ltd (SLBT) and CEO of YD Bio Ltd (YDES).
Signal8 holds 6 ownership filings by Shen Ethan PhD (2 Form 3, 4 Form 4), filed between Mar 18, 2026 and Nov 3, 2026. Those filings report 3 transactions, from Sep 4, 2026 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shen Ethan PhD's filings is in TAIPEI.
Recent filings by Shen Ethan PhD
Other insiders filing for SL Science Holding Ltd (SLBT)
- Wang Ching-Dong, Chief Executive Officer
- LAU JOHNSON SHUN-PONG, Officer
- Xu Qian, Director
- Liu Mingche, Director
- Chen Kwo-Liang, Director
- General John Conrad, Director